President Donald Trump on Tuesday announced a deal with Pfizer to sell its drugs at lower prices to Medicaid patients.
Pfizer will now sell some drugs on a “direct to consumer” website called “TrumpRx,” which would be operated by the federal government.
The deal struck between the Trump administration and Pfizer will give the pharmaceutical manufacturer a three-year grace period on Trump’s planned tariffs on pharmaceuticals made outside the country, which will take effect Wednesday.
NBC News reported:
The agreement on lower prices will cover “a large majority” of Pfizer’s primary care medicines, along with speciality brand-name drugs, which will…
Read the full article at BREITBART.COM
